查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1985926

北美動物實驗醫學市場：市場規模、佔有率和趨勢分析（按產品、動物模型、應用、客戶和國家分類），細分市場預測（2026-2033 年）

North America Laboratory Animal Medicine Market Size, Share & Trends Analysis Report By Product, By Animal Model, By Application (Rodents, Rabbits, Non-Human Primates ), By Customer, By Country, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

北美動物實驗醫學市場概況

北美動物實驗室藥物市場預計到 2025 年將達到 34 億美元，預計到 2033 年將達到 51.8 億美元，2026 年至 2033 年的複合年成長率為 5.48%。

市場成長的促進因素包括：公共診斷和監測實驗室網路的擴張、對動物健康研究和開發以及受監管實驗室基礎設施的資本投資、動物護理標準和監管要求的收緊，以及仍然依賴生物模型的應用研究領域的成長。

對動物用藥品研發和監管檢測設施的投資是該產業成長的關鍵驅動力。對生技藥品生產和研發設施的大規模、多年期投資正在擴大產能，並上游工程臨床前研究和驗證活動。新建的研發實驗室整合到製造地內，增加了製劑測試、穩定性測試和監管申報所需的體內研究量。例如，默克動物保健公司於2025年5月宣布，將投資8.95億美元擴大其位於堪薩斯州德索託的生技藥品生產設施。這些活動正在持續推動對獸醫監管、健康監測和受監管動物飼養設施的需求。

在更嚴格的監管下，向符合良好實驗室規範 (GLP) 認證的實驗室過渡，進一步加速了這一成長。認證提高了對數據完整性、可追溯性和可重複性的期望，從而對與動物健康相關的變數進行更嚴格的控制。例如，2025 年 7 月，查克河實驗室 (CRL) 成為加拿大第一個獲得 GLP 認證的實驗室，具備處理放射性物質和進行臨床前放射性藥物研究的能力。此前，加拿大標準委員會根據經合組織 (OECD) 針對加拿大衛生署和美國食品藥物管理局 (FDA) 等監管機構制定的標準進行了審核。依照 GLP 標準運作的機構需要更頻繁的診斷、標準化的預防保健通訊協定以及記錄動物福利結果。這提高了每隻動物的醫療保健密度，而不僅僅是增加動物數量。

另一個關鍵的市場促進因素是公共診斷和監測實驗室網路的擴展。這一趨勢正在提高實驗動物醫療保健活動的規模、強度和規律性。各國政府正在建立永久性診斷系統，以進行動物疾病檢測、疫苗評估和安全性研究。這提高了人們對整個實驗動物群體持續健康監測、標準化診斷和有記錄的獸醫監管的期望。隨著實驗室透過正式網路合作，檢測通訊協定和品質要求也日趨統一。這有助於提高每隻動物的檢測頻率，廣泛應用確診方法，並延長健康監測週期。動物健康數據現在不再僅在發生急性事件時才生成，而是定期生成。這種轉變正在推動對診斷劑、熟練的獸醫人員以及符合生物安全措施的飼養系統的需求。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：市場波動因素、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 價值鏈分析
    • 監理和倫理框架
    • 上游工程投入及相關供應商
    • 產品開發、檢驗和製造
    • 法規與合規
    • 分銷和物流
    • 藥品和生物製藥的最終用戶
    • 臨床前試驗和合約研究實驗室
    • 學術和研究機構
    • 下游服務、生命週期管理與價值創造
  • 研發投資和資金籌措趨勢
    • 製藥和生物製藥公司的內部研發投資
    • 研發領域臨床前CRO的資本配置與業務運營
    • 轉化研究的私人資本與資金籌措管道
    • 政策方向、倫理優先事項和資金重新分配
  • 經營模式分析
    • OEM市場進入模式
    • 直銷模式與銷售代理商/經銷商模式
    • 捆綁式產品和服務以及長期供應合約
  • 定價分析
  • 技術與實務的趨勢
    • 診斷和健康監測產品
    • 治療藥物和預防藥物
    • 臨床護理設備和裝置
    • 臨床/福利耗材
    • 其他輔助科技和作業系統
  • 客戶類型與購買行為分析
    • 大製藥和生技公司
    • CRO（委外研發機構）
    • 學術與研究機構、大學醫院
    • 政府、國家研究機構
  • 動物實驗醫學在臨床前試驗流程中的作用
    • 臨床獸醫學和動物福利
    • 研究設計、手術支援和通訊協定實施
    • 設施運作、生物安全和法規遵從
    • 資料完整性、品質保證和員工培訓
  • 市場分析工具
    • 波特五力分析
    • 利用SWOT分析進行PESTEL分析

第4章：北美動物實驗醫學市場：依產品類別分類的估算與趨勢分析

  • 北美動物實驗醫學市場：依產品類別分類的波動分析
  • 北美動物實驗醫學市場估算與預測：依產品分類（2021-2033 年）
  • 診斷和健康監測產品
    • 血清及PCR檢測套組
    • 微生物和寄生蟲檢測
    • 臨床化學及血液學試劑/試劑盒
    • 其他
  • 治療藥物和預防藥物
    • 疫苗
    • 感染疾病物（抗生素、抗病毒藥物、抗真菌藥物）
    • 抗寄生蟲藥物（用於體內和體外寄生蟲）
    • 止痛藥和鎮靜劑
    • 麻醉劑
    • 抗發炎藥物和支持性治療藥物
    • 其他
  • 臨床護理設備和裝置
    • 動物病患監測設備
    • 麻醉機/蒸發器
    • 人工呼吸器和呼吸支持系統
    • 輸液幫浦/注射式幫浦
    • 臨床影像診斷設備
    • 其他
  • 臨床/福利耗材
    • 針頭、注射器、導管和血管通路包。
    • 繃帶、創傷護理和外科耗材
    • 消毒劑、清潔劑、衛生用品
    • 個人防護設備（PPE）、防護耗材
    • 其他
  • 其他產品

第5章：北美動物實驗醫學市場：依動物模型分類的估算與趨勢分析

  • 北美動物實驗醫學市場：以動物模型分類的波動分析
  • 北美動物實驗醫學市場估計與預測：按動物模型分類（2021-2033 年）
  • 囓齒動物
  • 兔子
  • 非人靈長類（NHP）
  • 其他動物

第6章：北美動物實驗室醫學市場：按應用分類的估算與趨勢分析

  • 北美動物實驗醫學市場：波動分析（按應用領域分類）
  • 北美動物實驗醫學市場估算與預測：按應用領域分類（2021-2033 年）
    • 疾病監測，蜂群健康監測
    • 預防保健、生物安全
    • 手術全期護理（麻醉、鎮痛、手術支持）
    • 慢性病管理/支持性護理
    • 福利和行為評估
    • 臨終關懷，安樂死管理
    • 培訓、教育和合規性支持
    • 其他

第7章：北美動物實驗醫學市場：按客戶群分類的估算與趨勢分析

  • 北美動物實驗醫學市場：按客戶群分類的波動分析
  • 北美動物實驗醫學市場估算與預測：按客戶類型分類（2021-2033 年）
    • 製藥和生物製藥公司
    • 臨床前CRO，合約檢查室
    • 學術和研究機構
    • 其他

第8章：北美動物實驗醫學市場：國別估算與趨勢分析

  • 市場概覽：按國家/地區
  • 市場佔有率分析：按國家/地區分類（2025 年和 2033 年）
  • 美國
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範
  • 加拿大
    • 主要國家的趨勢
    • 競爭格局
    • 法律規範

第9章 競爭情勢

  • 參與企業的分類
    • 市場領導
    • 新興企業
  • 市佔率/估值分析（熱圖分析）（2025 年）
  • 公司簡介
    • Zoetis Services LLC
    • Boehringer Ingelheim International GmbH
    • Merck &Co., Inc.
    • Dechra
    • Elanco Animal Health
    • Kent Scientific Corporation
    • Harvard Apparatus
    • Starr
    • QIAGEN
    • Neogen Corporation
    • Mediso Ltd.
    • IITCINC
    • Thermo Fisher Scientific Inc.
    • Plas-Labs, Inc.
    • TSE Systems
    • CH Technologies（USA）, Inc
Product Code: GVR-4-68040-859-7

North America Laboratory Animal Medicine Market Summary

The North America laboratory animal medicine market size was estimated at USD 3.40 billion in 2025 and is projected to reach USD 5.18 billion by 2033, growing at a CAGR of 5.48% from 2026 to 2033. The market growth is driven by the expansion of public diagnostic and surveillance laboratory networks, capital investment in animal health R&D and regulated laboratory infrastructure, tightening animal care standards and oversight expectations, and growth in applied research areas that still depend on in vivo models.

Capital investment in animal health R&D and regulated laboratory infrastructure is one of the crucial dynamic drivers for the sector growth. Large, multi-year investments in biologics manufacturing and research facilities expand production capacity and upstream preclinical and validation activity. New R&D laboratories integrated within manufacturing campuses increase the volume of in vivo studies required for formulation testing, stability work, and regulatory submissions. For instance, in May 2025, Merck Animal Health announced USD 895 million expansion of its De Soto, Kansas, biologics manufacturing facility. Such activities are bringing sustained demand for veterinary oversight, health monitoring, and compliant animal housing.

The path towards highly regulated, GLP-certified laboratories is further amplifying this growth. Certification raises expectations for data integrity, traceability, and repeatability, thereby enabling tighter control over animal health variables. For instance, in July 2025, Chalk River Laboratories (CRL) became Canada's first GLP-certified lab capable of radioactive work and pre-clinical radiopharmaceutical studies, following a Standards Council of Canada audit that adhered to OECD standards for regulators such as Health Canada and the FDA. Facilities operating under GLP standards require more frequent diagnostics, standardized preventive care protocols, and documented welfare outcomes. This increases healthcare intensity per animal rather than depending on simple growth in animal numbers.

Another important driver for the market is the expansion of public diagnostic and surveillance laboratory networks. This dynamic has been increasing the scale, intensity, and regularity of laboratory animal healthcare activities. Governments are building permanent diagnostic capacity for detecting animal diseases, evaluating vaccines, and conducting safety investigations. This has raised expectations for continuous health monitoring, standardized diagnostics, and documented veterinary oversight across laboratory animal populations. As laboratories become connected through formal networks, testing protocols and quality requirements are becoming more uniform. This drives higher testing frequency per animal, broader use of confirmatory diagnostics, and longer health-monitoring timelines. Animal health data is now generated on a routine basis rather than only during acute events. That change increases demand for diagnostic reagents, skilled veterinary staff, and compliant animal housing systems that support biosecure operations.

North America Laboratory Animal Medicine Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the NA laboratory animal medicine market report based on product, animal model, application, customer, and country:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics & Health Surveillance Products
    • Serology & PCR Test Kits
    • Microbiology & Parasitology Assays
    • Clinical Chemistry & Hematology Reagents / Panels
    • Others
  • Therapeutics & Preventive Medicines
    • Vaccines
    • Anti-infectives (Antibiotics, Antivirals, Antifungals)
    • Antiparasitics (Endo- & Ecto-parasite Control)
    • Analgesics & Sedatives
    • Anesthetics
    • Anti-inflammatory & Supportive Care Drugs
    • Others
  • Clinical Care Devices & Equipment
    • Animal Patient Monitoring Devices
    • Anesthesia Machines & Vaporizers
    • Ventilators & Respiratory Support Systems
    • Infusion & Syringe Pumps
    • Clinical Imaging & Diagnostic Devices
    • Others
  • Clinical & Welfare Consumables
    • Needles, Syringes, Catheters & Vascular Access Sets
    • Bandages, Wound Care & Surgical Consumables
    • Disinfectants, Detergents & Sanitation Products
    • Personal Protective Equipment (PPE) & Barrier Consumables
    • Others
  • Others Products
  • Animal Model Outlook (Revenue, USD Million, 2021 - 2033)
  • Rodents
  • Rabbits
  • Non-Human Primates (NHPs)
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Surveillance & Colony Health Monitoring
  • Preventive Care & Biosecurity
  • Perioperative Care (Anesthesia, Analgesia, Surgical Support)
  • Chronic Disease Management & Supportive Care
  • Welfare & Behavioral Assessment
  • End-of-Life & Euthanasia Management
  • Training, Education & Compliance Support
  • Others
  • Customer Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • Preclinical CROs & Contract Laboratories
  • Academic & Research Institutions
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • U.S.
  • Canada

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Model
    • 1.2.3. Application
    • 1.2.4. Customer
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Bottom-Up Analysis
    • 1.7.2. Model 2: Volume-Pricing Analysis
    • 1.7.3. Model 3: Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion Of Public Diagnostic And Surveillance Laboratory Networks
      • 3.2.1.2. Capital Investment In Animal Health R&D And Regulated Laboratory Infrastructure
      • 3.2.1.3. Strengthening Animal Care Standards And Oversight Expectations
      • 3.2.1.4. Growth In Applied Research Areas That Still Depend On In Vivo Models
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Policy Pressure To Reduce Or Replace Animal Testing
      • 3.2.2.2. Public Funding Uncertainty And Research Budget Cuts
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Value Chain Analysis
    • 3.3.1. Regulatory And Ethical Framework
    • 3.3.2. Upstream Inputs And Enabling Suppliers
    • 3.3.3. Product Development, Validation, And Manufacturing
    • 3.3.4. Regulatory And Compliance
    • 3.3.5. Distribution And Logistics
    • 3.3.6. Pharmaceutical And Biopharmaceutical End Users
    • 3.3.7. Preclinical Cros And Contract Laboratories
    • 3.3.8. Academic And Research Institutions
    • 3.3.9. Downstream Services, Lifecycle Management, And Value Capture
  • 3.4. R&D Investment & Funding Landscape
    • 3.4.1. Pharmaceutical And Biopharmaceutical Internal R&D Investment
    • 3.4.2. Preclinical Cro Capital Allocation And Operational R&D
    • 3.4.3. Private Capital And Translational Funding Pathways
    • 3.4.4. Policy Direction, Ethical Priorities, And Funding Reallocation
  • 3.5. Business Model Analysis
    • 3.5.1. OEM Go-To-Market Models
    • 3.5.2. Direct Sales Vs. Distributor / Dealer Models
    • 3.5.3. Bundled Offerings And Long-Term Supply Agreements
  • 3.6. Pricing Analysis
  • 3.7. Technology & Practice Landscape
    • 3.7.1. Diagnostics And Health Surveillance Products
    • 3.7.2. Therapeutics And Preventive Medicines
    • 3.7.3. Clinical Care Devices And Equipment
    • 3.7.4. Clinical And Welfare Consumables
    • 3.7.5. Other Supporting Technologies And Operational Systems
  • 3.8. Customer Types and Buying Behavior Analysis
    • 3.8.1. Large Pharmaceutical And Biotechnology Companies
    • 3.8.2. Contract Research Organizations (CROs)
    • 3.8.3. Academic Research Institutions And Teaching Hospitals
    • 3.8.4. Government And National Research Laboratories
  • 3.9. Role of Laboratory Animal Medicine in Preclinical Study Workflows
    • 3.9.1. Clinical Veterinary Care And Animal Welfare
    • 3.9.2. Study Design, Surgical Support, And Protocol Execution
    • 3.9.3. Facility Operations, Biosafety, And Regulatory Compliance
    • 3.9.4. Data Integrity, Quality Assurance, And Staff Training
  • 3.10. Market Analysis Tools
    • 3.10.1. Porter's Five Forces Analysis
    • 3.10.2. PESTEL by SWOT Analysis

Chapter 4. North America Laboratory Animal Medicine Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America Laboratory Animal Medicine Market, By Product Movement Analysis
  • 4.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4. Diagnostics & Health Surveillance Products
    • 4.4.1. Diagnostics & Health Surveillance Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Serology & PCR Test Kits
      • 4.4.2.1. Serology & PCR Test Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Microbiology & Parasitology Assays
      • 4.4.3.1. Microbiology & Parasitology Assays Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Clinical Chemistry & Hematology Reagents / Panels
      • 4.4.4.1. Clinical Chemistry & Hematology Reagents / Panels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Therapeutics & Preventive Medicines
    • 4.5.1. Therapeutics & Preventive Medicines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Vaccines
      • 4.5.2.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Anti-infectives (Antibiotics, Antivirals, Antifungals)
      • 4.5.3.1. Anti-infectives (Antibiotics, Antivirals, Antifungals) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Antiparasitics (Endo- & Ecto-parasite Control)
      • 4.5.4.1. Antiparasitics (Endo- & Ecto-parasite Control) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Analgesics & Sedatives
      • 4.5.5.1. Analgesics & Sedatives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Anesthetics
      • 4.5.6.1. Anesthetics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Anti-inflammatory & Supportive Care Drugs
      • 4.5.7.1. Anti-inflammatory & Supportive Care Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.8. Others
      • 4.5.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Clinical Care Devices & Equipment
    • 4.6.1. Clinical Care Devices & Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Animal Patient Monitoring Devices
      • 4.6.2.1. Animal Patient Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Anesthesia Machines & Vaporizers
      • 4.6.3.1. Anesthesia Machines & Vaporizers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Ventilators & Respiratory Support Systems
      • 4.6.4.1. Ventilators & Respiratory Support Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Infusion & Syringe Pumps
      • 4.6.5.1. Infusion & Syringe Pumps Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.6. Clinical Imaging & Diagnostic Devices
      • 4.6.6.1. Clinical Imaging & Diagnostic Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.7. Others
      • 4.6.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Clinical & Welfare Consumables
    • 4.7.1. Clinical & Welfare Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Needles, Syringes, Catheters & Vascular Access Sets
      • 4.7.2.1. Needles, Syringes, Catheters & Vascular Access Sets Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Bandages, Wound Care & Surgical Consumables
      • 4.7.3.1. Bandages, Wound Care & Surgical Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Disinfectants, Detergents & Sanitation Products
      • 4.7.4.1. Disinfectants, Detergents & Sanitation Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Personal Protective Equipment (PPE) & Barrier Consumables
      • 4.7.5.1. Personal Protective Equipment (PPE) & Barrier Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.6. Others
      • 4.7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Other Products
    • 4.8.1. Other Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America Laboratory Animal Medicine Market: Animal Model Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America Laboratory Animal Medicine Market, By Animal Model Movement Analysis
  • 5.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, by Animal Model, 2021 to 2033 (USD Million)
  • 5.4. Rodents
    • 5.4.1. Rodents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Rabbits
    • 5.5.1. Rabbits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Non-Human Primates (NHPs)
    • 5.6.1. Non-Human Primates (NHPs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others Animals
    • 5.7.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America Laboratory Animal Medicine Market: By Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. North America Laboratory Animal Medicine Market, By Application Movement Analysis
  • 6.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, By Application, 2021 to 2033 (USD Million)
    • 6.3.1. Disease Surveillance & Colony Health Monitoring
      • 6.3.1.1. Disease Surveillance & Colony Health Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Preventive Care & Biosecurity
      • 6.3.2.1. Preventive Care & Biosecurity Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Perioperative Care (Anesthesia, Analgesia, Surgical Support)
      • 6.3.3.1. Perioperative Care (Anesthesia, Analgesia, Surgical Support) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Chronic Disease Management & Supportive Care
      • 6.3.4.1. Chronic Disease Management & Supportive Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Welfare & Behavioral Assessment
      • 6.3.5.1. Welfare & Behavioral Assessment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. End-of-Life & Euthanasia Management
      • 6.3.6.1. End-of-Life & Euthanasia Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Training, Education & Compliance Support
      • 6.3.7.1. Training, Education & Compliance Support Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Others
      • 6.3.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America Laboratory Animal Medicine Market: By Customer Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. North America Laboratory Animal Medicine Market, By Customer Movement Analysis
  • 7.3. North America Laboratory Animal Medicine Market Estimates & Forecasts, by Customer, 2021 to 2033 (USD Million)
    • 7.3.1. Pharmaceutical & Biopharmaceutical Companies
      • 7.3.1.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Preclinical CROs & Contract Laboratories
      • 7.3.2.1. Preclinical CROs & Contract Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Academic & Research Institutions
      • 7.3.3.1. Academic & Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Others
      • 7.3.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America Laboratory Animal Medicine Market: By Country Estimates & Trend Analysis

  • 8.1. Country Market Dashboard
  • 8.2. Country Market Share Analysis, 2025 & 2033
  • 8.3. U.S
    • 8.3.1. Key Country Dynamics
    • 8.3.2. Competitive Scenario
    • 8.3.3. Regulatory Framework
    • 8.3.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Canada
    • 8.4.1. Key Country Dynamics
    • 8.4.2. Competitive Scenario
    • 8.4.3. Regulatory Framework
    • 8.4.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Zoetis Services LLC
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Boehringer Ingelheim International GmbH
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Merck & Co., Inc.
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Dechra
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Elanco Animal Health
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Kent Scientific Corporation
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Harvard Apparatus
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Starr
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. QIAGEN
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Neogen Corporation
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Mediso Ltd.
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. IITCINC
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Thermo Fisher Scientific Inc.
      • 9.3.13.1. Participant's Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Product Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Plas-Labs, Inc.
      • 9.3.14.1. Participant's Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Product Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. TSE Systems
      • 9.3.15.1. Participant's Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Product Benchmarking
      • 9.3.15.4. Strategic Initiatives
    • 9.3.16. CH Technologies (USA), Inc
      • 9.3.16.1. Participant's Overview
      • 9.3.16.2. Financial Performance
      • 9.3.16.3. Product Benchmarking
      • 9.3.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Laboratory Animal Medicine Market, By Country, 2021 - 203 (USD Million)
  • Table 4 U.S. Laboratory Animal Medicine Market, By Product, 2021 - 203 (USD Million)
  • Table 5 U.S. Laboratory Animal Medicine Market, By Diagnostics & Health Surveillance Products , 2021 - 203 (USD Million)
  • Table 6 U.S. Laboratory Animal Medicine Market, By Therapeutics & Preventive Medicines , 2021 - 203 (USD Million)
  • Table 7 U.S. Laboratory Animal Medicine Market, By Clinical Care Devices & Equipment , 2021 - 203 (USD Million)
  • Table 8 U.S. Laboratory Animal Medicine Market, By Clinical & Welfare Consumables , 2021 - 203 (USD Million)
  • Table 9 U.S. Laboratory Animal Medicine Market, By Animal Model, 2021 - 203 (USD Million)
  • Table 10 U.S. Laboratory Animal Medicine Market, By Application, 2021 - 203 (USD Million)
  • Table 11 U.S. Laboratory Animal Medicine Market, By Customer, 2021 - 203 (USD Million)
  • Table 12 Canada Laboratory Animal Medicine Market, By Product, 2021 - 203 (USD Million)
  • Table 13 Canada Laboratory Animal Medicine Market, By Diagnostics & Health Surveillance Products , 2021 - 203 (USD Million)
  • Table 14 Canada Laboratory Animal Medicine Market, By Therapeutics & Preventive Medicines , 2021 - 203 (USD Million)
  • Table 15 Canada Laboratory Animal Medicine Market, By Clinical Care Devices & Equipment , 2021 - 203 (USD Million)
  • Table 16 Canada Laboratory Animal Medicine Market, By Clinical & Welfare Consumables , 2021 - 203 (USD Million)
  • Table 17 Canada Laboratory Animal Medicine Market, By Animal Model, 2021 - 203 (USD Million)
  • Table 18 Canada Laboratory Animal Medicine Market, By Application, 2021 - 203 (USD Million)
  • Table 19 Canada Laboratory Animal Medicine Market, By Customer, 2021 - 203 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 North America Laboratory Animal Medicine Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Country Marketplace: Key Takeaways
  • Fig. 14 North America Laboratory Animal Medicine Market, for Product, 2021 - 203 (USD Million)
  • Fig. 15 North America Laboratory Animal Medicine Market, for Diagnostics & Health Surveillance Products , 2021 - 203 (USD Million)
  • Fig. 16 North America Laboratory Animal Medicine Market, for Serology & PCR Test Kits , 2021 - 203 (USD Million)
  • Fig. 17 North America Laboratory Animal Medicine Market, for Microbiology & Parasitology Assays , 2021 - 203 (USD Million)
  • Fig. 18 North America Laboratory Animal Medicine Market, for Clinical Chemistry & Hematology Reagents / Panels , 2021 - 203 (USD Million)
  • Fig. 19 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 20 North America Laboratory Animal Medicine Market, for Therapeutics & Preventive Medicines , 2021 - 203 (USD Million)
  • Fig. 21 North America Laboratory Animal Medicine Market, for Vaccines , 2021 - 203 (USD Million)
  • Fig. 22 North America Laboratory Animal Medicine Market, for Anti-infectives (Antibiotics, Antivirals, Antifungals) , 2021 - 203 (USD Million)
  • Fig. 23 North America Laboratory Animal Medicine Market, for Antiparasitics (Endo- & Ecto-parasite Control) , 2021 - 203 (USD Million)
  • Fig. 24 North America Laboratory Animal Medicine Market, for Analgesics & Sedatives , 2021 - 203 (USD Million)
  • Fig. 25 North America Laboratory Animal Medicine Market, for Anesthetics , 2021 - 203 (USD Million)
  • Fig. 26 North America Laboratory Animal Medicine Market, for Anti-inflammatory & Supportive Care Drugs , 2021 - 203 (USD Million)
  • Fig. 27 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 28 North America Laboratory Animal Medicine Market, for Clinical Care Devices & Equipment , 2021 - 203 (USD Million)
  • Fig. 29 North America Laboratory Animal Medicine Market, for Animal Patient Monitoring Devices , 2021 - 203 (USD Million)
  • Fig. 30 North America Laboratory Animal Medicine Market, for Anesthesia Machines & Vaporizers , 2021 - 203 (USD Million)
  • Fig. 31 North America Laboratory Animal Medicine Market, for Ventilators & Respiratory Support Systems , 2021 - 203 (USD Million)
  • Fig. 32 North America Laboratory Animal Medicine Market, for Infusion & Syringe Pumps , 2021 - 203 (USD Million)
  • Fig. 33 North America Laboratory Animal Medicine Market, for Clinical Imaging & Diagnostic Devices , 2021 - 203 (USD Million)
  • Fig. 34 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 35 North America Laboratory Animal Medicine Market, for Clinical & Welfare Consumables , 2021 - 203 (USD Million)
  • Fig. 36 North America Laboratory Animal Medicine Market, for Needles, Syringes, Catheters & Vascular Access Sets , 2021 - 203 (USD Million)
  • Fig. 37 North America Laboratory Animal Medicine Market, for Bandages, Wound Care & Surgical Consumables , 2021 - 203 (USD Million)
  • Fig. 38 North America Laboratory Animal Medicine Market, for Disinfectants, Detergents & Sanitation Products , 2021 - 203 (USD Million)
  • Fig. 39 North America Laboratory Animal Medicine Market, for Personal Protective Equipment (PPE) & Barrier Consumables, 2021 - 203 (USD Million)
  • Fig. 40 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 41 North America Laboratory Animal Medicine Market, for Others, 2021 - 203 (USD Million)
  • Fig. 42 North America Laboratory Animal Medicine Market, for Animal Model, 2021 - 203 (USD Million)
  • Fig. 43 North America Laboratory Animal Medicine Market, for Rodents , 2021 - 203 (USD Million)
  • Fig. 44 North America Laboratory Animal Medicine Market, for Rabbits , 2021 - 203 (USD Million)
  • Fig. 45 North America Laboratory Animal Medicine Market, for Non-Human Primates , 2021 - 203 (USD Million)
  • Fig. 46 North America Laboratory Animal Medicine Market, for Others , 2021 - 203 (USD Million)
  • Fig. 47 North America Laboratory Animal Medicine Market, for Application, 2021 - 203 (USD Million)
  • Fig. 48 North America Laboratory Animal Medicine Market, for Disease Surveillance & Colony Health Monitoring , 2021 - 203 (USD Million)
  • Fig. 49 North America Laboratory Animal Medicine Market, for Preventive Care & Biosecurity , 2021 - 203 (USD Million)
  • Fig. 50 North America Laboratory Animal Medicine Market, for Perioperative Care (Anesthesia, Analgesia, Surgical Support) , 2021 - 203 (USD Million)
  • Fig. 51 North America Laboratory Animal Medicine Market, for Chronic Disease Management & Supportive Care 2021 - 203 (USD Million)
  • Fig. 52 North America Laboratory Animal Medicine Market, for Welfare & Behavioral Assessment 2021 - 203 (USD Million)
  • Fig. 53 North America Laboratory Animal Medicine Market, for End-of-Life & Euthanasia Management 2021 - 203 (USD Million)
  • Fig. 54 North America Laboratory Animal Medicine Market, for Training, Education & Compliance Support 2021 - 203 (USD Million)
  • Fig. 55 North America Laboratory Animal Medicine Market, for Others 2021 - 203 (USD Million)
  • Fig. 56 North America Laboratory Animal Medicine Market, for Customer type 2021 - 203 (USD Million)
  • Fig. 57 North America Laboratory Animal Medicine Market, for Pharmaceutical & Biopharmaceutical Companies 2021 - 203 (USD Million)
  • Fig. 58 North America Laboratory Animal Medicine Market, for Preclinical CROs & Contract Laboratories 2021 - 203 (USD Million)
  • Fig. 59 North America Laboratory Animal Medicine Market, for Academic & Research Institutions 2021 - 203 (USD Million)
  • Fig. 60 North America Laboratory Animal Medicine Market, for Others 2021 - 203 (USD Million)
  • Fig. 61 U.S. Laboratory Animal Medicine Market, 2021 - 203 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Canada Laboratory Animal Medicine Market, 2021 - 203 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Key Company Categorization
  • Fig. 66 Heat Map Analysis
  • Fig. 67 Strategic Framework